David Grahame Grahame-Smith: clinical pharmacologist. 1933-2011.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3403213)

Published in Br J Clin Pharmacol on May 01, 2012

Authors

Jeffrey K Aronson1

Author Affiliations

1: British Pharmacological Society, Green-Templeton College, Oxford, UK.

Articles cited by this

Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem (1971) 3.34

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response. Br J Clin Pharmacol (1977) 1.44

Tryptophan hydroxylation in brain. Biochem Biophys Res Commun (1964) 1.04

The biosynthesis of 5-hydroxytryptamine in brain. Biochem J (1967) 1.03

The Lilly Prize Lecture. 1996 keep on taking the tablets': pharmacological adaptation during long-term drug therapy. Br J Clin Pharmacol (1997) 1.00

The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients. Br J Clin Pharmacol (1981) 0.97

Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia. Br J Clin Pharmacol (1979) 0.93

Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy. Klin Wochenschr (1981) 0.84

A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole. Br J Clin Pharmacol (1989) 0.81

Letter: Hyphens. Lancet (1976) 0.81

Processes regulating the functional activity of brain 5-hydroxytryptamine: results of animal experimentation and their relevance to the understanding and treatment of depression. Pharmakopsychiatr Neuropsychopharmakol (1978) 0.80

Albert Neuberger. Biogr Mem Fellows R Soc (2001) 0.80